A generalization of the area under the ROC curve to weight more heavily the early recognition of active compounds.
Source: PAC, 2016,
88, 239. (
Glossary of terms used in computational drug design, part II (IUPAC Recommendations 2015)) on page 242 [
Terms] [
Paper]